Karyopharm Therapeutics logo
Karyopharm Therapeutics
KPTI | NASDAQ
Chart Builder DCF Calculator
$0.11
-$0.55 (-83.38%)
At close: Nov 2, 2026, 4:00 PM ET

Karyopharm Therapeutics Income Statement

Income statement explained
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
146.62M 151.12M 146.07M 142.53M 137.27M 142.13M 145.24M 148.44M 145.67M 140.46M 146.03M 145.87M 146M 148.1M 157.07M 249.76M 251.31M 234.23M 209.82M 118.65M 102.29M 113.21M
6.04M 6.01M 5.95M 5.8M 4.98M 5.49M 6.18M 6.42M 6.03M 5.66M 5.02M 5.32M 5.39M 5.14M 5.21M 4.09M 3.7M 3.9M 3.4M 3.71M 3.56M 2.82M
140.58M 145.11M 140.12M 136.73M 132.29M 136.64M 139.05M 142.03M 139.64M 134.8M 141.01M 140.54M 140.61M 142.96M 151.86M 245.68M 247.61M 230.33M 206.42M 114.94M 98.73M 110.39M
-82.35M -84.21M -90.71M -104.14M -115.21M -118.94M -119.44M -125.97M -130.95M -132.4M -129.54M -125.6M -125.18M -138.52M -142.2M -61.37M -74.34M -80.48M -98.27M -182.3M -185.6M -176.87M
2.39M 2.28M 2.77M 3.65M 4.93M 6.24M 7.4M 8.44M 9.36M 10.25M 10.94M 9.76M 7.67M 5.13M 2.36M 1.08M 520K 392K 582K 923K 1.43M 2.11M
-224.77M -194.96M -196M -124.62M -123.57M -62.5M -76.37M -87.18M -89.63M -146M -142.78M -139.5M -141.29M -157.73M -164.92M -87.89M -103.32M -107.82M -123.82M -205.78M -207.52M -200.36M
-224.74M -194.97M -196.04M -124.62M -123.57M -62.52M -76.42M -87.48M -89.91M -146.34M -143.1M -139.77M -141.59M -158.02M -165.29M -88.07M -103.55M -108.07M -124.09M -206.23M -207.91M -200.76M
101.98M 104.54M 105.21M 109.63M 110.65M 113.24M 115.44M 118.94M 122.11M 125.52M 131.88M 135.84M 139.68M 142.54M 145.4M 145.31M 145.77M 144.96M 143.85M 143.21M 139.08M 133.39M
121.94M 124.78M 125.62M 131.25M 136.84M 142.33M 143.06M 149.06M 148.48M 141.67M 138.67M 130.3M 126.11M 138.94M 148.66M 161.73M 176.18M 165.85M 160.84M 154.02M 145.25M 153.87M
-988K – – – – – – – – – – – – – – – – – – – -141K -202K
222.93M 229.32M 230.83M 240.88M 247.49M 255.58M 258.5M 268M 270.59M 267.2M 270.55M 266.14M 265.79M 281.48M 294.06M 307.05M 321.96M 310.82M 304.69M 297.24M 284.33M 287.26M
49.32M 47.41M 45.85M 44.43M 44.81M 42.53M 37.42M 32.43M 27.11M 23.95M 23.82M 23.5M 23.54M 24.07M 25M 27.05M 28.95M 27.64M 26.05M 25.18M 23.97M 25.73M
– – – – – – – – – – – – – – – – – – – – – –
228.97M 235.33M 236.77M 246.67M 252.48M 261.07M 264.68M 274.41M 276.62M 272.86M 275.57M 271.47M 271.18M 286.62M 299.28M 311.13M 325.65M 314.71M 308.09M 300.95M 287.89M 290.07M
-32K 8K 43K 1K -5K 22K 57K 296K 280K 340K 323K 266K 299K 293K 369K 175K 236K 249K 268K 451K 389K 392K
28.94M 22.01M 6.74M 8.67M 8.62M 8.47M 8.39M 8.33M 8.07M 7.7M 7.65M 7.63M 7.59M 7.57M 6M 5.35M 5.31M 5.17M 5.05M 5.03M 5.01M 4.97M
28.94M 24.72M 18.22M 8.67M 8.62M 8.47M 8.39M 8.33M 10.29M 7.7M 7.65M 7.63M 7.61M 7.57M 6M 5.35M 5.31M 5.17M 5.79M 5.03M 5.01M 4.97M
-22.32 -24.32 -26.07 -8.10 -8.13 -7.60 -9.68 -17.96 -18.63 -19.14 -18.80 -13.76 -9.69 -6.01 -2.03 -1.09 -10.94 -11.03 -11.27 -12.37 -12.99 -21.79
-13.07 -15.07 -16.60 -8.10 -8.13 -6.78 -8.86 -17.14 -17.81 -19.13 -18.79 -13.75 -9.68 -6.01 -2.03 -1.14 -1.38 -1.47 -1.71 -2.76 -12.99 -21.79
-175.85M -147.88M -150.4M -80.38M -78.44M -19.64M -38.6M -54.42M -62.19M -121.72M -118.42M -115.44M -117.08M -132.92M -139.31M -60.19M -73.72M -79.46M -96.99M -179.69M -182.6M -173.67M
-176M -148.11M -150.7M -80.74M -78.76M -19.97M -38.94M -54.76M -62.52M -122.05M -118.95M -116M -117.75M -133.66M -139.93M -60.84M -74.37M -80.19M -97.77M -180.6M -183.55M -174.64M
149K 230K 296K 358K 320K 333K 340K 336K 333K 325K 530K 566K 668K 734K 621K 647K 651K 731K 789K 907K 956K 965K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.